Towards Healthcare

News

Your marketplace is evolving, your competitors are readjusting – but instead of reacting you can proact

Max Healthcare Expands Strongly in Delhi-NCR with Smart Growth Strategy
14 July 2025

Max Healthcare Expands Strongly in Delhi-NCR with Smart Growth Strategy

Max Healthcare is Set to Flourish in the Healthcare Industry Image Credits: The Financial Express Efforts The hospital chain is expanding and focusing on growth in the Delhi-NCR region. The region is experiencing excellent growth in margins and ARPOB, and occupancy, which reflects the early day...

Novartis and Pan-Canadian Finalize Deal to Make Cosentyx Accessible for HS Patients
14 July 2025

Novartis and Pan-Canadian Finalize Deal to Make Cosentyx Accessible for HS Patients

Novartis and Pan-Canadian’s Partnership has Finalized Negotiations Announcement Novartis Pharmaceuticals Canada Inc. finally confirms its partnership with Pan-Canadian Pharmaceutical by settling down with an effective negotiation on (Pcpa) public reimbursement of Cosentyx (secukinumab) for...

Pelthos Launches FDA-Approved ZELSUVMI Gel for Skin Infection Molluscum Contagiosum
14 July 2025

Pelthos Launches FDA-Approved ZELSUVMI Gel for Skin Infection Molluscum Contagiosum

Pelthos Introduces New Medicine in the Healthcare Market Image Credits: eMPR Announcement Ligand Pharmaceuticals Incorporated partner Pelthos Therapeutics Inc has commercially introduced ZELSUVMI (berdazimer) topical gel 10.3%, which is an FDA-approved (at-home treatment) for molluscum contagio...

Connect Biopharma’s Partner Simcere Submits New Drug Application for Atopic Dermatitis in China
11 July 2025

Connect Biopharma’s Partner Simcere Submits New Drug Application for Atopic Dermatitis in China

Connect Biopharma’s Partner Company to Submit its New Drug Application Announcement Connect Biopharma Holdings Limited, a biopharmaceutical company known for its unique care for the treatment of inflammatory disease, has proudly announced that its partner company, and a China-licensed comp...

Inventiva Appoints New Leaders to Strengthen MASH Drug Development
11 July 2025

Inventiva Appoints New Leaders to Strengthen MASH Drug Development

Inventiva Announced a New Member for the Company Image Credits: The Pharma Letter Announcement Inventiva, a biopharmaceutical company known for the development of oral therapies mainly for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), is happy to experience a transit...

Biocytogen and BeOne Medicines Sign Antibody Licensing Agreement to Boost Cancer Treatment Innovations
11 July 2025

Biocytogen and BeOne Medicines Sign Antibody Licensing Agreement to Boost Cancer Treatment Innovations

Biocytogen and BeOne Medicines’ Licensing Agreement Image Credits: Biocytogen Announcement Biocytogen [Pharmaceuticals Co., Ltd., a leading biotechnology company that excels in research and development of antibody-based drugs with its innovative technologies] has signed a licensing agreem...

Rhythm Pharmaceuticals Announces $150 Million Public Offering to Fuel Growth in Rare Disease Treatments
11 July 2025

Rhythm Pharmaceuticals Announces $150 Million Public Offering to Fuel Growth in Rare Disease Treatments

The Proposed Public Offering of Rhythm’s Image Credits: AInvest Announcement Rhythm Pharmaceuticals Inc., a commercial-based biopharmaceutical company, has nearly improved the lives of rare neuroendocrine patients and has released the proposed public offering of $150 million of its common...

BioNxt Solutions Unveils Breakthrough Chemotherapy Delivery Platform for Targeted Cancer Treatment
10 July 2025

BioNxt Solutions Unveils Breakthrough Chemotherapy Delivery Platform for Targeted Cancer Treatment

BioNxt Solutions' Overview of New Advancements in the Healthcare Market Image Credits: Irish Sun Announcement BioNxt Solutions Inc., a biopharmaceutical company known for its advanced drug-delivery technologies, has introduced a new advancement in the potential development, focusing on the chem...

Quanterix Completes Acquisition of Akoya Biosciences to Expand Biomarker Capabilities
10 July 2025

Quanterix Completes Acquisition of Akoya Biosciences to Expand Biomarker Capabilities

Quanterix closed the acquisition of Akoya Biosciences Image Credits: BioPharma APAC Announcement Quanterix Corporation, a leading company with its core scientific discovery via an ultra-sensitive biomarker identifier, has completed its previous acquisition of Akoya Biosciences Inc., a leader in...

Six Biotech Startups Redefining Aging and Skin Health with Cutting-Edge Innovations
10 July 2025

Six Biotech Startups Redefining Aging and Skin Health with Cutting-Edge Innovations

Six Biotech Companies’ Initiative to Shape the Evergreen Age Image Credits: Faster Capital Announcement The modern era, which is experiencing and adopting computational techniques and deep biological knowledge, expects a change in rejuvenating the concerned area, as aging has been a core ...